Arcus Biosciences, Inc. Quarterly Nonoperating Income (Expense) in USD from Q1 2017 to Q3 2024

Taxonomy & unit: us-gaap: USD
Description: The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary: Arcus Biosciences, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q1 2017 to Q3 2024.
Arcus Biosciences, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2024 was $13M, a 18.2% increase year-over-year.
Arcus Biosciences, Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was $49M, a 40.8% increase year-over-year.
Arcus Biosciences, Inc. annual Nonoperating Income (Expense) for 2023 was $39M, a 179% increase from 2022.
Arcus Biosciences, Inc. annual Nonoperating Income (Expense) for 2022 was $14M, a 1300% increase from 2021.
Arcus Biosciences, Inc. annual Nonoperating Income (Expense) for 2021 was $1M, unchanged from 2020.

Nonoperating Income (Expense), Trailing 12 Months (USD)

Nonoperating Income (Expense), Quarterly (USD)

Nonoperating Income (Expense), YoY Quarterly Growth (%)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q3 2024	$49M	$13M	+$2M	+18.2%	Jul 1, 2024	Sep 30, 2024	10-Q	2024-11-06
Q2 2024	$47M	$13M	+$4M	+44.4%	Apr 1, 2024	Jun 30, 2024	10-Q	2024-08-08
Q1 2024	$43M	$12M	+$4M	+50%	Jan 1, 2024	Mar 31, 2024	10-Q	2024-05-08
Q4 2023	$39M	$11M	+$4.19M	+61.6%	Oct 1, 2023	Dec 31, 2023	10-K	2024-02-21
Q3 2023	$34.8M	$11M	+$6M	+120%	Jul 1, 2023	Sep 30, 2023	10-Q	2024-11-06
Q2 2023	$28.8M	$9M	+$7M	+350%	Apr 1, 2023	Jun 30, 2023	10-Q	2024-08-08
Q1 2023	$21.8M	$8M	+$7.81M	+4088%	Jan 1, 2023	Mar 31, 2023	10-Q	2024-05-08
Q4 2022	$14M	$6.81M	+$6.29M	+1212%	Oct 1, 2022	Dec 31, 2022	10-K	2024-02-21
Q3 2022	$7.71M	$5M	+$4.84M	+3006%	Jul 1, 2022	Sep 30, 2022	10-Q	2023-11-07
Q2 2022	$2.87M	$2M	+$1.83M	+1105%	Apr 1, 2022	Jun 30, 2022	10-Q	2023-08-07
Q1 2022	$1.04M	$191K	+$37K	+24%	Jan 1, 2022	Mar 31, 2022	10-Q	2022-05-09
Q4 2021	$1M	$519K	+$737K		Oct 1, 2021	Dec 31, 2021	10-K	2024-02-21
Q3 2021	$263K	$161K	-$109K	-40.4%	Jul 1, 2021	Sep 30, 2021	10-Q	2022-11-02
Q2 2021	$372K	$166K	-$135K	-44.9%	Apr 1, 2021	Jun 30, 2021	10-Q	2022-08-03
Q1 2021	$507K	$154K	-$493K	-76.2%	Jan 1, 2021	Mar 31, 2021	10-Q	2022-05-09
Q4 2020	$1M	-$218K	-$1.15M	-123%	Oct 1, 2020	Dec 31, 2020	10-K	2023-02-28
Q3 2020	$2.15M	$270K	-$627K	-69.9%	Jul 1, 2020	Sep 30, 2020	10-Q	2021-11-08
Q2 2020	$2.77M	$301K	-$769K	-71.9%	Apr 1, 2020	Jun 30, 2020	10-Q	2021-08-05
Q1 2020	$3.54M	$647K	-$456K	-41.3%	Jan 1, 2020	Mar 31, 2020	10-Q	2021-05-05
Q4 2019	$4M	$929K	-$260K	-21.9%	Oct 1, 2019	Dec 31, 2019	10-K	2022-02-23
Q3 2019	$4.26M	$897K	-$436K	-32.7%	Jul 1, 2019	Sep 30, 2019	10-Q	2020-11-05
Q2 2019	$4.7M	$1.07M	-$1.3M	-54.8%	Apr 1, 2019	Jun 30, 2019	10-Q	2020-08-06
Q1 2019	$5.99M	$1.1M	+$726K	+193%	Jan 1, 2019	Mar 31, 2019	10-Q	2020-05-05
Q4 2018	$5.27M	$1.19M	+$1.06M	+794%	Oct 1, 2018	Dec 31, 2018	10-K	2021-02-25
Q3 2018	$4.21M	$1.33M	+$1.32M	+11008%	Jul 1, 2018	Sep 30, 2018	10-Q	2019-11-05
Q2 2018	$2.89M	$2.37M	+$2.25M	+1975%	Apr 1, 2018	Jun 30, 2018	10-Q	2019-08-06
Q1 2018	$636K	$377K	+$277K	+277%	Jan 1, 2018	Mar 31, 2018	10-Q	2019-05-02
Q4 2017	$359K	$133K			Oct 1, 2017	Dec 31, 2017	10-K	2019-03-05
Q3 2017		$12K			Jul 1, 2017	Sep 30, 2017	10-Q	2018-11-08
Q2 2017		$114K			Apr 1, 2017	Jun 30, 2017	10-Q	2018-08-06
Q1 2017		$100K			Jan 1, 2017	Mar 31, 2017	10-Q	2018-05-09

* An asterisk sign (*) next to the value indicates that the value is likely invalid.